With better drugs for high cholesterol, doctors become more ambitious with their treatment goals Share via In a new strategy for preventing heart attacks and strokes, leading cardiologists are urging their fellow physicians to focus on reducing the LDL cholesterol of patients at greatest risk of suffering a cardiovascular crisis, and to use costly new drugs if necessary
The swing became especially visible in 2023, when nearly half of all T2D patients who began a GLP-1 did so within just one month of their diagnosis
This suggests that microbial and metabolic disruptions become increasingly entrenched over time, highlighting the urgent need for early, targeted interventions using specialized prebiotic fibers to halt the progression of dysbiosis and restore SCFA production before permanent neurological damage occurs
Why Brooklyn patients choose GoalBMI Wellness Fully online process Start and continue care from home no clinic visits required
This is why many GLP-1 drugs, like Ozempic and Mounjaro, were first approved for type 2 diabetesbefore being approved for weight management
You have residual concerns that diet and exercise cant correct
